Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 42, Issue 10, 2013, Pages 755-760

  Abdulmajeed, Ahmad A ^a,b   Dalley, Andrew J ^a,b   Farah, Camile S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ALDH1; CD24; CD271; CD44; Oral cancer; Oral epithelial dysplasia

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOFORM 1; CD24 ANTIGEN; CD271 ANTIGEN; HERMES ANTIGEN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; ISOENZYME; LEUKOCYTE ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; RETINAL DEHYDROGENASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STEM CELL; CHILD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; ORAL BIOPSY; ORAL EPITHELIAL DYSPLASIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; TUMOR BIOPSY; CELL TRANSFORMATION; CHEMISTRY; DISEASE COURSE; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PRECANCER; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD24; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PRECANCEROUS CONDITIONS; RECEPTORS, NERVE GROWTH FACTOR; RETINAL DEHYDROGENASE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84887181851     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12073     Document Type: Article

References (39)

1. McCullough MJ, Prasad G, Farah CS. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Aust Dent J 2010; 55: 61-5.
2. Farah CS, Ford PJ, Allen K, Vu A. Oral cancer and potentially cancerous lesions - early detection and diagnosis. In: Ogbureke KUE, ed. Oral cancer. Rijeka: InTech, 2012; 79-106.
3. Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa - diagnostic problems and prognostic features. Curr Diagn Pathol 2006; 12: 11-21.
4. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009; 138: 822-829.
5. Dick JE. Stem cell concepts renew cancer research. Blood 2008; 112: 4793-807.
6. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-68.
7. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-8.
8. Boiko AD, Razorenova OV, Van DRM, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133-7.
9. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-8.
10. Alison MR, Guppy NJ, Lim SML, Nicholson LJ. Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose? J Pathol 2010; 222: 335-44.
11. Feng JQ, Xu ZY, Shi LJ, et al. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer. J Oral Pathol Med 2013; 42: 148-53.
12. Yoshida A, Hsu LC, Dave V. Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme 1992; 46: 239-44.
13. Visus C, Ito D, Amoscato A, et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8 + T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res 2007; 67: 10538-45.
14. Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-13.
15. Nakamura T, Endo K, Kinoshita S. Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling. Stem Cells 2007; 25: 628-38.
16. Okumura T, Shimada Y, Imamura M, Yasumoto S. Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 2003; 22: 4017-26.
17. Huang SD, Yuan Y, Liu XH, et al. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer 2009; 9: 9.
18. Kiyosue T, Kawano S, Matsubara R, et al. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Int J Clin Oncol 2013; 18: 154-63.
19. Dalley AJ, Abdulmajeed AA, Upton Z, Farah CS. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75(NTR) in malignancy. J Oral Pathol Med 2013; 42: 37-46.
20. Verdi JM, Birren SJ, Ibanez CF, et al. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 1994; 12: 733-45.
21. Wang X, Bauer JH, Li Y, et al. Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model. J Biol Chem 2001; 276: 33812-20.
22. Isacke CM. The role of the cytoplasmic domain in regulating CD44 function. J Cell Sci 1994; 9: 2353-9.
23. Bankfalvi A, Krassort M, Buchwalow IB, et al. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol 2002; 198: 343-51.
24. Kristiansen G, Schluns K, Yongwei Y, et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 2003; 88: 231-6.
25. Sagiv E, Memeo L, Karin A, et al. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131: 630-9.
26. Bircan S, Kapucuoglu N, Baspinar S, Inan G, Inan GCandir O. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathol Res Pract 2006; 202: 569-76.
27. Winkler A, Zigeuner R, Rehak P, et al. CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 2007; 450: 59-64.
28. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-33.
29. Chaw SY, Abdul MA, Dalley AJ, et al. Epithelial to mesenchymal transition (EMT) biomarkers - E-cadherin, beta-catenin, APC and Vimentin - in oral squamous cell carcinogenesis and transformation. Oral Oncol 2012; 48: 997-1006.
30. Tzankov A, Zlobec I, Went P, et al. Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores. Leuk Lymphoma 2010; 51: 199-212.
31. Su Y, Qiu Q, Zhang X, et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 327-37.
32. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-8.
33. Han J, Kioi M, Chu WS, et al. Identification of potential therapeutic targets in human head & neck squamous cell carcinoma. Head Neck Oncol 2009; 1: 27.
34. Sano A, Kato H, Sakurai S, et al. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16: 506-14.
35. Redondo P, Garcia-Foncillas J, Okroujnov I, de Felipe I, Quintanilla E. CD24 expression on human keratinocytes. Exp Dermatol 1998; 7: 175-8.
36. Grotenhuis BA, Dinjens WN, Wijnhoven BP, et al. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers. J Pathol 2010; 221: 379-89.
37. Riener MO, Vogetseder A, Pestalozzi BC, et al. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 2010; 41: 1558-65.
38. Roye GD, Myers RB, Brown D, et al. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 1996; 69: 254-8.
39. Washington K, Gottfried MR, Telen MJ. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 1994; 25: 1043-9.